Strata Critical Medical Acquires Heart And Lung Transplant National Recovery Program For $21.5M

Strata Critical Medical, Inc. Class A

Strata Critical Medical, Inc. Class A

SRTA

0.00

Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), today announced that it has completed the acquisition of Heart and Lung Transplant National Recovery Program ("HLT-NRP"), a provider of transplant surgical recovery services in the United States.

The transaction value of $21.5 million consists of approximately 80% cash and 20% stock, which will be released from a multi-year lockup based on the Seller’s continued participation in the business. 

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.